OncoCyte Corporation (LON:0KCC)
London
· Delayed Price · Currency is GBP · Price in USD 3.080
0.00 (0.00%)
At close: Apr 24, 2025
OncoCyte Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -60.66 | -27.78 | -72.9 | -64.1 | -29.93 | Upgrade
|
| Depreciation & Amortization | 1.56 | 1.68 | 5.22 | 4.21 | 0.39 | Upgrade
|
| Other Amortization | - | - | 0.01 | 0.06 | 0.1 | Upgrade
|
| Asset Writedown & Restructuring Costs | 42.07 | 8.04 | 44.55 | - | 0.42 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 0.06 | 0.47 | -0.23 | -0.3 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | 0.27 | 1.55 | Upgrade
|
| Stock-Based Compensation | 1.91 | 2.89 | 10.04 | 6.84 | 5.07 | Upgrade
|
| Other Operating Activities | -4.28 | -5.76 | -31.02 | 16.86 | -5.26 | Upgrade
|
| Change in Accounts Receivable | -1.13 | 0.11 | -0.58 | -1.23 | -0.18 | Upgrade
|
| Change in Inventory | -0.41 | - | - | - | - | Upgrade
|
| Change in Accounts Payable | 0.97 | -4.76 | 0.3 | -1.35 | 0.85 | Upgrade
|
| Change in Other Net Operating Assets | -0.75 | 0.68 | -1.66 | 2.73 | 1.32 | Upgrade
|
| Operating Cash Flow | -20.71 | -23.33 | -45.57 | -35.94 | -25.98 | Upgrade
|
| Capital Expenditures | -0.52 | -0.28 | -4.34 | -2.25 | -1.23 | Upgrade
|
| Sale of Property, Plant & Equipment | 0 | 0.35 | - | - | - | Upgrade
|
| Cash Acquisitions | - | - | - | -11.71 | -6.51 | Upgrade
|
| Investment in Securities | - | 0.37 | - | - | -4 | Upgrade
|
| Other Investing Activities | - | -1.37 | - | - | -0.01 | Upgrade
|
| Investing Cash Flow | -0.51 | -0.93 | -4.34 | -13.96 | -11.75 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 1.14 | Upgrade
|
| Long-Term Debt Repaid | -0.2 | -0.12 | -1.43 | -1.53 | -0.45 | Upgrade
|
| Net Debt Issued (Repaid) | -0.2 | -0.12 | -1.43 | -1.53 | 0.7 | Upgrade
|
| Issuance of Common Stock | 27.81 | 13.85 | 32.84 | 83.2 | 22.25 | Upgrade
|
| Repurchase of Common Stock | - | - | - | -0.24 | -0.01 | Upgrade
|
| Other Financing Activities | -1.8 | -0.43 | -0.48 | -3.07 | -0.13 | Upgrade
|
| Financing Cash Flow | 20.43 | 12.19 | 35.81 | 78.36 | 22.8 | Upgrade
|
| Net Cash Flow | -0.8 | -12.07 | -14.1 | 28.46 | -14.93 | Upgrade
|
| Free Cash Flow | -21.23 | -23.61 | -49.91 | -38.19 | -27.21 | Upgrade
|
| Free Cash Flow Margin | -1128.60% | -1570.59% | -5209.60% | -1737.40% | -2237.42% | Upgrade
|
| Free Cash Flow Per Share | -1.62 | -3.08 | -9.01 | -8.59 | -8.31 | Upgrade
|
| Cash Interest Paid | 0.04 | 0.01 | 0.02 | 0.11 | 0.21 | Upgrade
|
| Levered Free Cash Flow | -14.03 | -10.6 | -11.22 | -6.71 | -13.95 | Upgrade
|
| Unlevered Free Cash Flow | -13.97 | -10.57 | -11.18 | -6.64 | -13.89 | Upgrade
|
| Change in Net Working Capital | 2.41 | 0.92 | 0.52 | -1.92 | -2.2 | Upgrade
|
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.